{
    "document_id": 10751,
    "page": 11,
    "width_pt": 595.32,
    "height_pt": 841.92,
    "rotation": 0,
    "pipeline_version": "paddleocr-vl-1.6+paul-48",
    "engine": "paddleocr_vl",
    "source_run_id": 10862,
    "item_count": 12,
    "counts_by_type": {
        "figure": 1,
        "footer": 2,
        "heading": 1,
        "link": 6,
        "text": 2
    },
    "build_ms": 1,
    "items": [
        {
            "id": "p11.1",
            "order": 1,
            "type": "figure",
            "bbox": {
                "l": 386.5621,
                "t": 841.92,
                "r": 594.6001,
                "b": 685.44
            },
            "text": "",
            "attrs": {
                "role": "page_header",
                "block_label": "header_image"
            }
        },
        {
            "id": "p11.2",
            "order": 2,
            "type": "heading",
            "bbox": {
                "l": 40.3119,
                "t": 626.64,
                "r": 186.4424,
                "b": 609.6
            },
            "text": "Fees for registration",
            "attrs": {
                "block_label": "paragraph_title"
            },
            "level": 3
        },
        {
            "id": "p11.3",
            "order": 3,
            "type": "text",
            "bbox": {
                "l": 39.592,
                "t": 602.4,
                "r": 290.3415,
                "b": 542.16
            },
            "text": "There has been one fee change during 2021/22. We increased the renewal fee for pharmacy premises on 1 April 2021, from £262 to £365. All other fees have stayed the same."
        },
        {
            "id": "p11.4",
            "order": 4,
            "type": "text",
            "bbox": {
                "l": 39.1121,
                "t": 537.12,
                "r": 289.8616,
                "b": 394.32
            },
            "text": "From March to June 2021, we consulted on\nproposals to help us develop our fees\nstrategy and our overall approach to fee\n setting. This was part of our long-term financial strategy.\nWe will use what we heard during the\nconsultation as we continue to develop the next steps in our fee strategy, as part of our work on long-term financial planning.",
            "children": [
                {
                    "id": "p11.4.1",
                    "order": 5,
                    "type": "link",
                    "bbox": {
                        "l": 175.15,
                        "t": 537.63,
                        "r": 292.8,
                        "b": 522.65
                    },
                    "text": "we consulted on",
                    "attrs": {
                        "uri": "https://www.pharmacyregulation.org/previous-consultations#Fee-review-2021",
                        "action_type": "/URI"
                    }
                },
                {
                    "id": "p11.4.2",
                    "order": 6,
                    "type": "link",
                    "bbox": {
                        "l": 40.3,
                        "t": 522.65,
                        "r": 292.8,
                        "b": 507.67
                    },
                    "text": "proposals to help us develop our fees",
                    "attrs": {
                        "uri": "https://www.pharmacyregulation.org/previous-consultations#Fee-review-2021",
                        "action_type": "/URI"
                    }
                },
                {
                    "id": "p11.4.3",
                    "order": 7,
                    "type": "link",
                    "bbox": {
                        "l": 40.3,
                        "t": 507.67,
                        "r": 292.8,
                        "b": 492.69
                    },
                    "text": "strategy and our overall approach to fee",
                    "attrs": {
                        "uri": "https://www.pharmacyregulation.org/previous-consultations#Fee-review-2021",
                        "action_type": "/URI"
                    }
                },
                {
                    "id": "p11.4.4",
                    "order": 8,
                    "type": "link",
                    "bbox": {
                        "l": 40.3,
                        "t": 492.69,
                        "r": 83.117,
                        "b": 477.71
                    },
                    "text": "setting.",
                    "attrs": {
                        "uri": "https://www.pharmacyregulation.org/previous-consultations#Fee-review-2021",
                        "action_type": "/URI"
                    }
                },
                {
                    "id": "p11.4.5",
                    "order": 9,
                    "type": "link",
                    "bbox": {
                        "l": 100.3,
                        "t": 456.73,
                        "r": 292.8,
                        "b": 441.75
                    },
                    "text": "what we heard during the",
                    "attrs": {
                        "uri": "https://www.pharmacyregulation.org/sites/default/files/document/consultation-on-fee-review-analysis-report-september-2021.pdf",
                        "action_type": "/URI"
                    }
                },
                {
                    "id": "p11.4.6",
                    "order": 10,
                    "type": "link",
                    "bbox": {
                        "l": 40.3,
                        "t": 441.75,
                        "r": 114.14,
                        "b": 426.77
                    },
                    "text": "consultation",
                    "attrs": {
                        "uri": "https://www.pharmacyregulation.org/sites/default/files/document/consultation-on-fee-review-analysis-report-september-2021.pdf",
                        "action_type": "/URI"
                    }
                }
            ]
        },
        {
            "id": "p11.5",
            "order": 11,
            "type": "footer",
            "bbox": {
                "l": 39.3521,
                "t": 58.56,
                "r": 439.8313,
                "b": 30.96
            },
            "text": "General Pharmaceutical Council\nAnnual report: annual fitness to practise report and annual accounts 2021/22",
            "attrs": {
                "block_label": "footer"
            }
        },
        {
            "id": "p11.6",
            "order": 12,
            "type": "footer",
            "bbox": {
                "l": 538.4515,
                "t": 57.36,
                "r": 552.6086,
                "b": 44.64
            },
            "text": "11",
            "attrs": {
                "block_label": "number"
            }
        }
    ],
    "excluded_furniture": {
        "first": [],
        "last": []
    }
}